美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
63739-203-18	63739-203	HUMAN PRESCRIPTION DRUG	Atovaquone	Atovaquone	SUSPENSION	ORAL	20240419	N/A	ANDA	ANDA214272	McKesson Corporation dba SKY Packaging	ATOVAQUONE	750 mg/5mL	3 TRAY in 1 CASE (63739-203-18) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (63739-203-05)
63739-203-42	63739-203	HUMAN PRESCRIPTION DRUG	Atovaquone	Atovaquone	SUSPENSION	ORAL	20240419	N/A	ANDA	ANDA214272	McKesson Corporation dba SKY Packaging	ATOVAQUONE	750 mg/5mL	7 TRAY in 1 CASE (63739-203-42) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (63739-203-05)
0121-1016-18	0121-1016	HUMAN PRESCRIPTION DRUG	Atovaquone	Atovaquone	SUSPENSION	ORAL	20240110	N/A	ANDA	ANDA214272	PAI Holdings, LLC	ATOVAQUONE	750 mg/5mL	3 TRAY in 1 CASE (0121-1016-18) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1016-05)
0121-1016-42	0121-1016	HUMAN PRESCRIPTION DRUG	Atovaquone	Atovaquone	SUSPENSION	ORAL	20240110	N/A	ANDA	ANDA214272	PAI Holdings, LLC	ATOVAQUONE	750 mg/5mL	7 TRAY in 1 CASE (0121-1016-42) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1016-05)
42239-001-08	42239-001	HUMAN PRESCRIPTION DRUG	Atovaquone	Atovaquone	SUSPENSION	ORAL	20231114	N/A	ANDA	ANDA214272	Abon Pharmaceuticals, LLC	ATOVAQUONE	750 mg/5mL	1 BOTTLE in 1 CARTON (42239-001-08) / 210 mL in 1 BOTTLE